Patents Assigned to IRIDEX
-
Patent number: 11931294Abstract: A treatment probe for treating an eye of a patient includes an elongate body that defines a handle and a treatment fiber that is housed within the elongate body. The treatment fiber is configured to deliver treatment light energy to the eye. A contact member is disposed on an end of the elongate body. The contact member has a contact surface for positioning on a surface of the eye, two side edges that are positioned on opposite sides of the contact surface, and a fluid channel. The contact surface conforms to the shape of the eye's sclera and the two side edges are shaped to direct fluid that is present on the surface of the eye toward the fluid channel when the contact member is moved laterally across the surface of the eye. The fluid aggregates within the fluid channel and contacts a distal end of the treatment fiber.Type: GrantFiled: May 3, 2022Date of Patent: March 19, 2024Assignee: IRIDEX CorporationInventors: Howard Chen, George Marcellino
-
Publication number: 20230364438Abstract: A lens or eye mask for treating an eye of a patient includes a flexible printed circuit board (PCB) that is configured to fit over at least a portion of a surface of the eye and a plurality of electrode pairs that are arranged on the flexible PCB. An electrical source is configured to provide electrical energy to each electrode pair to create a near electromagnetic field within the eye and thereby therapeutically treat target tissue within the eye. A spacing between electrodes of each electrode pair is controlled to achieve a predetermined penetration depth of the near electromagnetic field within the eye.Type: ApplicationFiled: July 26, 2023Publication date: November 16, 2023Applicant: IRIDEX CorporationInventor: Howard Chen
-
Publication number: 20230355441Abstract: An ophthalmic treatment system and method for performing therapy on target tissue in a patient's eye. A delivery system delivers treatment light to the patient's eye and a camera captures a live image of the patient's eye. Control electronics control the delivery system, register a pre-treatment image of the patient's eye to the camera's live image (where the pre-treatment image includes a treatment template that identifies target tissue within the patient's eye), and verify whether or not the delivery system is aligned to the target tissue defined by the treatment template. The control electronics control the delivery system to project the treatment light onto the patient's eye in response to both an activation of a trigger device and the verification that the delivery system is aligned. to the target tissue, as well as adjust delivery system alignment to track eye movement.Type: ApplicationFiled: May 5, 2023Publication date: November 9, 2023Applicant: IRIDEX CorporationInventor: Steven Thomas Charles
-
Patent number: 11745024Abstract: A lens or eye mask for treating an eye of a patient includes a flexible printed circuit board (PCB) that is configured to fit over at least a portion of a surface of the eye and a plurality of electrode pairs that are arranged on the flexible PCB. An electrical source is configured to provide electrical energy to each electrode pair to create a near electromagnetic field within the eye and thereby therapeutically treat target tissue within the eye. A spacing between electrodes of each electrode pair is controlled to achieve a predetermined penetration depth of the near electromagnetic field within the eye.Type: GrantFiled: December 17, 2019Date of Patent: September 5, 2023Assignee: IRIDEX CorporationInventor: Howard Chen
-
Patent number: 11690761Abstract: Systems, devices, and methods for treating a glaucomatous eye are provided. An amount of pulsed laser energy is delivered to the pars plana of the eye by a hand-holdable device which comprises a hand-holdable elongate member and a contact member disposed on an end of the elongate member. A contact surface of the contact member is placed in direct contact with the eye so that a reference edge of the contact member aligns with the limbus and a treatment axis defined by the elongate member is angularly offset from the optical axis of the eye. The amount of pulsed laser energy delivered is insufficient to effect therapeutic photocoagulation but is sufficient to increase uveoscleral outflow so as to maintain a reduction from pre-laser treatment intraocular pressure. Amounts of pulsed laser energy will be transmitted to a circumferential series of tissue regions of the eye.Type: GrantFiled: September 2, 2021Date of Patent: July 4, 2023Assignees: IRIDEX Corporation, National University Hospital (Singapore) PTE LTD, National University of SingaporeInventors: Paul T. K. Chew, David M. Buzawa, Giorgio Dorin
-
Patent number: 11672704Abstract: An ophthalmic treatment system and method for performing therapy on target tissue in a patient's eye. A delivery system delivers treatment light to the patient's eye and a camera captures a live image of the patient's eye. Control electronics control the delivery system, register a pre-treatment image of the patient's eye to the camera's live image (where the pre-treatment image includes a treatment template that identifies target tissue within the patient's eye), and verify whether or not the delivery system is aligned to the target tissue defined by the treatment template. The control electronics control the delivery system to project the treatment light onto the patient's eye in response to both an activation of a trigger device and the verification that the delivery system is aligned to the target tissue, as well as adjust delivery system alignment to track eye movement.Type: GrantFiled: February 5, 2021Date of Patent: June 13, 2023Assignee: IRIDEX CorporationInventor: Steven Thomas Charles
-
Publication number: 20230141548Abstract: In some embodiments, an ophthalmic laser system may be provided that does not include a traditional laser console. Instead, the treatment device may be configured to house the treatment light source within the device handle. Additionally, in some embodiments, the handheld treatment device may include a user interface, such as dials and buttons, for adjusting various parameters of the therapeutic light. With certain embodiments, the self-contained handheld treatment device may be operated independent of an AC power source. For example, in some embodiments, the handheld treatment device may be battery powered. Additionally, the handheld treatment device may be disposable or may utilize replaceable distal tips in certain embodiments. Certain embodiments may be particularly designed for transscleral cyclophotocoagulation. Also, treatment guides are provided that may be configured to couple with a treatment device to align the device with a target tissue of the eye.Type: ApplicationFiled: January 12, 2023Publication date: May 11, 2023Applicant: IRIDEX CorporationInventors: Howard Chen, David Buzawa
-
Patent number: 11576569Abstract: In some embodiments, an ophthalmic laser system may be provided that does not include a traditional laser console. Instead, the treatment device may be configured to house the treatment light source within the device handle. Additionally, in some embodiments, the handheld treatment device may include a user interface, such as dials and buttons, for adjusting various parameters of the therapeutic light. With certain embodiments, the self-contained handheld treatment device may be operated independent of an AC power source. For example, in some embodiments, the handheld treatment device may be battery powered. Additionally, the handheld treatment device may be disposable or may utilize replaceable distal tips in certain embodiments. Certain embodiments may be particularly designed for transscleral cyclophotocoagulation. Also, treatment guides are provided that may be configured to couple with a treatment device to align the device with a target tissue of the eye.Type: GrantFiled: July 24, 2020Date of Patent: February 14, 2023Assignee: IRIDEX CorporationInventors: Howard Chen, David Buzawa
-
Publication number: 20220331161Abstract: A treatment probe for treating an eye of a patient includes an elongate body that defines a handle and a treatment fiber that is housed within the elongate body. The treatment fiber is configured to deliver treatment light energy to the eye. A contact member is disposed on an end of the elongate body. The contact member has a contact surface for positioning on a surface of the eye, two side edges that are positioned on opposite sides of the contact surface, and a fluid channel. The contact surface conforms to the shape of the eye's sclera and the two side edges are shaped to direct fluid that is present on the surface of the eye toward the fluid channel when the contact member is moved laterally across the surface of the eye. The fluid aggregates within the fluid channel and contacts a distal end of the treatment fiber.Type: ApplicationFiled: May 3, 2022Publication date: October 20, 2022Applicant: IRIDEX CorporationInventors: Howard Chen, George Marcellino
-
Patent number: 11406263Abstract: A photomedical system and method for treating and/or diagnosing a patient's eye that includes a first light source for producing light, a scanning device for deflecting the light to produce a pattern of the light on the eye, a viewing element positioned to view the eye by a user or physician, and an alignment element aligned to the viewing element and the scanning device for optically indicating through the viewing element a location on the eye on which the pattern of the light will be located, but without projecting any alignment light onto the eye.Type: GrantFiled: December 6, 2019Date of Patent: August 9, 2022Assignee: IRIDEX CorporationInventors: Michael W. Wiltberger, Dan E. Andersen, David H. Mordaunt
-
Publication number: 20220226151Abstract: In some embodiments, a system for providing a therapeutic treatment to a patient's eye includes a treatment beam source configured to transmit a treatment beam along a treatment beam path. The system further includes a processor coupled to the treatment beam source, the processor being configured to direct the treatment beam onto retinal tissue of the patient's eye and deliver a series of short duration pulses from the treatment beam onto the retinal tissue at a first treatment spot to treat the retinal tissue. In some embodiments, a pre-treatment evaluation method using electroretinography (ERG) data may be used to predict effects of treatment beams at different power values and to determine optimal power values.Type: ApplicationFiled: April 4, 2022Publication date: July 21, 2022Applicant: IRIDEX CorporationInventors: Howard Chen, George Marcellino
-
Publication number: 20220175580Abstract: Methods of treating an eye are provided that entail partially penetrating the sclera and delivering light energy from an optical fiber within the penetration to treat the a target tissue in the eye, for example, to coagulate vasculature underlying the sclera within a planned incision area. Also provided are treatment probes for treating an eye of a patient includes an elongate body that defines a handle and an advanceable penetrating member and optical fiber housed within the elongate body. The probe is configured to advance the penetrating member so as to penetrate the sclera, only partially, and advance the treatment fiber into the penetration to deliver treatment light energy to coagulate the vasculature underlying the sclera. The probe can include one or more penetrating members and corresponding optical fibers to form one or more penetrations concurrently within the planned incision area.Type: ApplicationFiled: December 7, 2021Publication date: June 9, 2022Applicant: IRIDEX CorporationInventors: Ken Arnold, George Marcellino
-
Patent number: 11351059Abstract: A treatment probe for treating an eye of a patient includes an elongate body that defines a handle and a treatment fiber that is housed within the elongate body. The treatment fiber is configured to deliver treatment light energy to the eye. A contact member is disposed on an end of the elongate body. The contact member has a contact surface for positioning on a surface of the eye, two side edges that are positioned on opposite sides of the contact surface, and a fluid channel. The contact surface conforms to the shape of the eye's sclera and the two side edges are shaped to direct fluid that is present on the surface of the eye toward the fluid channel when the contact member is moved laterally across the surface of the eye. The fluid aggregates within the fluid channel and contacts a distal end of the treatment fiber.Type: GrantFiled: June 28, 2019Date of Patent: June 7, 2022Assignee: IRIDEX CorporationInventors: Howard Chen, George Marcellino
-
Patent number: 11318048Abstract: In some embodiments, a system for providing a therapeutic treatment to a patient's eye includes a treatment beam source configured to transmit a treatment beam along a treatment beam path. The system further includes a processor coupled to the treatment beam source, the processor being configured to direct the treatment beam onto retinal tissue of the patient's eye and deliver a series of short duration pulses from the treatment beam onto the retinal tissue at a first treatment spot to treat the retinal tissue. In some embodiments, a pre-treatment evaluation method using electroretinography (ERG) data may be used to predict effects of treatment beams at different power values and to determine optimal power values.Type: GrantFiled: August 30, 2019Date of Patent: May 3, 2022Assignee: IRIDEX CorporationInventors: Howard Chen, George Marcellino
-
Publication number: 20220062036Abstract: An ophthalmic illumination method and system with a head-up display imaging system is provided wherein a therapeutic light is generated by a first laser light source configured to generate therapeutic light and a near-infrared wavelength of an alignment pattern is generated by a second laser light source, where the therapeutic light is directed upon an eye to be examined or treated in accordance with the alignment pattern.Type: ApplicationFiled: August 10, 2021Publication date: March 3, 2022Applicant: IRIDEX CorporationInventor: Chris Sramek
-
Patent number: 11143828Abstract: An optical switch incorporated in a photomedical system, and a method of treating tissue using the optical switch for creating pulsed light. A light source generates an optical beam. An aperture element includes a light-transmitting portion and a light-blocking portion. An optical element such as a mirror, prism or lens directs the optical beam to the aperture element, wherein the optical element is movable for translating the optical beam across the light-transmitting and light-blocking portions of the aperture element, or changing its angle of incidence through the aperture to produce one or more pulses of light from the optical beam. A lens focuses the one or more pulses of the optical beam onto target tissue. A controller controls the movement of the optical element to produce the one or more pulses of light.Type: GrantFiled: October 16, 2019Date of Patent: October 12, 2021Assignee: IRIDEX CorporationInventors: Michael W. Wiltberger, Dan E. Andersen, David H. Mordaunt
-
Publication number: 20210299466Abstract: A handheld device for delivering therapeutic light toward an eye of a patient includes a device housing that is configured to be held by a user in delivering the therapeutic light, a plurality of light sources disposed within the device housing, and an array of lenses disposed near the distal end of the device housing. Each light source is configured to independently emit a beam of therapeutic light and each lens of the array is aligned with a respective light source so that each beam of therapeutic light that is emitted from the respective light sources is focused and directed by the respective lenses of the array to target tissue of the eye in order to therapeutically treat to the target tissue.Type: ApplicationFiled: June 14, 2021Publication date: September 30, 2021Applicant: Iridex CorporationInventor: Howard Chen
-
Patent number: 11116663Abstract: An ophthalmic illumination method and system with a head-up display imaging system is provided wherein a therapeutic light is generated by a first laser light source configured to generate therapeutic light and a near-infrared wavelength of an alignment pattern is generated by a second laser light source, where the therapeutic light is directed upon an eye to be examined or treated in accordance with the alignment pattern.Type: GrantFiled: January 19, 2018Date of Patent: September 14, 2021Assignee: IRIDEX CorporationInventor: Chris Sramek
-
Patent number: 11116666Abstract: Systems, devices, and methods for treating a glaucomatous eye are provided. An amount of pulsed laser energy is delivered to the pars plana of the eye by a hand-holdable device which comprises a hand-holdable elongate member and a contact member disposed on an end of the elongate member. A contact surface of the contact member is placed in direct contact with the eye so that a reference edge of the contact member aligns with the limbus and a treatment axis defined by the elongate member is angularly offset from the optical axis of the eye. The amount of pulsed laser energy delivered is insufficient to effect therapeutic photocoagulation but is sufficient to increase uveoscleral outflow so as to maintain a reduction from pre-laser treatment intraocular pressure. Amounts of pulsed laser energy will be transmitted to a circumferential series of tissue regions of the eye.Type: GrantFiled: March 29, 2019Date of Patent: September 14, 2021Assignee: IRIDEX CorporationInventors: Paul T. K. Chew, David M. Buzawa, Giorgio Dorin
-
Publication number: 20210275829Abstract: A light based system for treating an eye includes a mask that is configured for positioning on the eye and a light source that is configured to deliver therapeutic light. The mask has an inner surface that is positionable against the eye and an outer surface that is opposite the inner surface. The mask is optically opaque to prevent transmission of light through the mask and the mask includes at least one transparent opening that allows transmission of light through the mask to target tissue of the eye posterior the transparent opening. The light source is positioned relative to the mask so that the delivered therapeutic light irradiates at least a portion of the mask and the transparent opening. Therapeutic light traverses through the transparent opening to the target tissue positioned posterior the transparent opening.Type: ApplicationFiled: May 4, 2021Publication date: September 9, 2021Applicant: IRIDEX CorporationInventor: Howard Chen